On November 1, 2022, Jack E. Stover notified PharmaCyte Biotech, Inc. (the Company) of his decision to resign from the board of directors of the Company, effective immediately. Mr. Stover's decision was not as a result of any disagreement with the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -0.47% | -0.47% | -2.31% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.31% | 17.84M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc. Announces Resignation of Jack E. Stover as Director